Notably, preclinical research into gene therapy for mucopolysaccharidoses (MPS) has been ongoing for the past three decades. At present, clinical trials for gene therapy targeting specific types of MPS are in progress in the United States, various European countries, and Australia.
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times